Safety Evaluation of an Expedited Omalizumab Home Self-Administration Pathway

Introduction The Northern Ireland Regional Immunology Service (NIRIS) has developed an expedited omalizumab home self-administration pathway to reduce face-to-face clinic attendance during the coronavirus disease 2019 (COVID-19) pandemic. This audit evaluates the safety of this pathway with a partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Zobia, Devlin, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584126/
https://www.ncbi.nlm.nih.gov/pubmed/34790499
http://dx.doi.org/10.7759/cureus.19434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584126/
https://www.ncbi.nlm.nih.gov/pubmed/34790499
http://dx.doi.org/10.7759/cureus.19434

Ejemplares similares